news
Eisai and Charles River Laboratories announce extension of integrated drug discovery partnership
Companies to continue collaboration in discovery of next generation anti-malaria drugs...
List view / Grid view
Eisai
news
Scientific milestone reached in Eisai – UCL Alzheimer’s collaboration
27 June 2016 | By Victoria White, Digital Content Producer
Eisai and UCL have reached the first scientific milestone in their neurodegenerative disease drug discovery and development collaboration...
news
Positive preclinical results for lenvatinib + everolimus in kidney cancer
19 April 2016 | By Victoria White, Digital Content Producer
New preclinical data show the combination of lenvatinib and everolimus yield greater antitumour activity than either agent alone in kidney cancer...
news
Eisai and Charles River announce drug discovery collaboration
15 February 2016 | By Victoria White
Eisai and Charles River have signed a collaboration agreement which will see Charles River scientists work at Eisai’s research and development facilities in Hatfield...
news
Eisai and IPC enter oncology R&D collaboration
4 November 2015 | By Victoria White
IPC will perform chemo-informatic virtual screening of a pre-selected Eisai chemical library, to identify new protein-protein inhibitors for further biological evaluation...
news
Study shows immunosuppressive effects of CA125 on farletuzumab
26 October 2015 | By Victoria White
The new findings have led to the hypothesis that patients with high levels of CA125 have an immunosuppressive tumour microenvironment that may potentially enable cancer cells to escape immune-mediated cytotoxicity...
news
Brain inflammation targeted in first Dementia Consortium drug discovery project
22 June 2015 | By Victoria White
The Dementia Consortium is funding a new project to target the immune system in the hunt for new treatments for Alzheimer's disease...
news
Eisai to promote clinical trial data disclosure for the advancement of science and medicine
26 May 2015 | By Victoria White
In order to promote transparency in clinical trial data disclosure, Eisai is making its clinical trial data available to researchers via an external website...
news
Genomics plc and Eisai to collaborate in analyses of large-scale genotype / phenotype data to inform drug discovery
13 April 2015 | By Victoria White
Eisai and Genomics are to collaborate to use Genomics' statistical analyses of large-scale multi-phenotype data to inform Eisai's drug discovery process...
news
Eisai and Biogen Idec enter collaboration to develop and commercialize Alzheimer’s disease treatments
5 March 2014 | By Biogen Idec
Eisai Co., Ltd. and Biogen Idec announced that they have entered into a collaboration to develop and commercialize two of Eisai’s clinical candidates for Alzheimer’s disease, E2609 and BAN2401...